Pluronic F127-based thermosensitive gels for delivery of therapeutic proteins and peptides

Polymer Reviews

Volumn 54, Issue 4, 2014, Pages 573-597

  Akash, Muhammad Sajid Hamid ^a,b   Rehman, Kanwal ^a,c   Chen, Shuqing ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b GOVERNMENT COLLEGE UNIVERSITY   (Pakistan)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Pluronic; proteinous drugs; sustained delivery; therapeutic proteins; thermosensitive gel

Indexed keywords

BIOCHEMISTRY; BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; FUNCTIONAL POLYMERS; GELS;

PLURONICS; PROTEINOUS DRUGS; SUSTAINED DELIVERY; THERAPEUTIC PROTEIN; THERMO-SENSITIVE GELS;

PEPTIDES;

EID: 84906853381     PISSN: 15583724     EISSN: 15583716     Source Type: Journal    
DOI: 10.1080/15583724.2014.927885     Document Type: Review

References (138)

1. Sinha, V. R.; Trehan, A. "Biodegradable microspheres for parenteral delivery", Crit. Rev. Ther. Drug Carrier Syst. 2005, 22, 535-602.
2. Ahmed, F.; Photos, P. J.; Discher, D. E. "Polymersomes as viral capsid mimics", Drug Dev. Res. 2006, 67, 4-14.
3. Chiappetta, D. A.; Sosnik, A. "Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugs", Eur. J. Pharm. Biopharm. 2007, 66, 303-317.
4. Agüeros, M.; Zabaleta, V.; Espuelas, S.; Campanero, M. A.; Irache, J. M. "Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles", J. Control. Release 2010, 145, 2-8.
5. Kabanov, A. V.; Batrakova, E. V. "New technologies for drug delivery across the blood brain barrier", Curr. Pharm. Des. 2004, 10, 1355-1363.
6. Trentin, D.; Hubbell, J.; Hall, H. "Non-viral gene delivery for local and controlled DNA release", J. Control. Release 2005, 102, 263-275.
7. Croy, S. R.; Kwon, G. S. "Polymeric micelles for drug delivery", Curr. Pharm. Des. 2006, 12, 4669-4684.
8. Batrakova, E. V.; Kabanov, A. V. "Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers", J. Control. Release 2008, 130, 98-106.
9. Jeong, B.; Bae, Y. H.; Kim, S. W. "Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers", J. Control. Release 2000, 63, 155-163.
10. Ahn, J. S.; Suh, J. M.; Lee, M.Y.; Jeong, B. "Sloweroding biodegradable multiblock poloxamer", Polym. Int. 2005, 54, 842-847.
11. Yu, L.; Zhang, Z.; Zhang, H.; Ding, J. "Biodegradability and biocompatibility of thermoreversible hydrogels formed from mixing a sol and a precipitate of block copolymers in water", Biomacromolecules 2010, 11, 2169-2178.
12. ® F127 copolymers for controlled protein release", Int. J. Pharm. 2013, 459, 1-9.
13. Sosnik, A.; Cohn, D. "Ethoxysilane-capped PEO-PPO-PEO triblocks: a new family of reverse thermo-responsive polymers", Biomaterials 2004, 25, 2851-2858.
14. Cheaburu, C.; Ciocoiu, O.; Staikos, G.; Vasile, C. "Thermoresponsive sodium alginate-g-poly(Nisopropylacrylamide) copolymers. III. Solution properties", J. Appl. Polym. Sci. 2013, 127, 3340-3348.
15. Cao, Y.; Rodriguez, A.; Vacanti, M.; Ibarra, C.; Arevalo, C.; Vacanti, C. A. "Comparative study of the use of poly(glycolic acid), calcium alginate and pluronics in the engineering of autologous porcine cartilage", J. Biomater. Sci. Polym. Ed. 1998, 9, 475-487.
16. Sosnik, A.; Sefton, M. V. "Semi-synthetic collagen/poloxamine matrices for Tissue Engineering applications", Biomaterials 2005, 26, 7425-7435.
17. Bromberg, L. "Properties of aqueous solutions and gels of poly(ethylene oxide)-b poly(propylene oxide)-b-poly(ethylene oxide)-g-poly(acrylic acid)", J. Phys. Chem. B 1998, 102, 10736-10744.
18. Kabanov, A.; Alakhov, V. "Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers", Crit. Rev. Ther. Drug. Carr. Syst. 2002, 19, 1-72.
19. Stratton, L. P.; Dong, A.; Manning, M. C.; Carpenter, J. F. "Drug delivery matrix containing native protein precipitates suspended in a polo-maxamer gel", J. Pharm. Sci. 1997, 86, 1006-1010.
20. Akash, M. S. H.; Rehman, K.; Sun, H.; Chen, S. "Assessment of release kinetics, stability and polymer interaction of PF127-based thermosensitive gel of interleutkin-1 receptor antagonist", Pharm. Dev. Technol. 2014, 19, 278-284.
21. Gong, C.; Qi, T.; Wei, X.; Qu, Y.; Wu, Q.; Luo, F.; Qian, Z. "Thermosensitive polymeric hydrogels as drug delivery systems", Curr. Med. Chem. 2013, 20, 79-94.
22. Shachaf, Y.; Gonen-Wadmany, M.; Seliktar, D. "The biocompatibility of PluronicF127 fibrinogen-based hydrogels", Biomaterials 2010, 31, 2836-2847.
23. Hwang, Y.S.; Chiang, P. R.; Hong, W. H.; Chiao, C. C.; Chu, I. M.; Hsiue, G. H.; Shen, C. R. "Study in vivo intraocular biocompatibility of in situ gelation hydrogels: poly(2-ethyl oxazoline)-block-poly(∈-caprolactone)- block-poly(2-ethyl oxazoline) copolymer, matrigel and pluronic F127", PLoS One 2013, 8, e67495.
24. Jeong, B.; Kim, S. W.; Bae, Y. H. "Thermosensitive sol-gel reversible hydrogels", Adv Drug Deliv. Rev. 2012, 64, 154-162.
25. Batrakova, E. V.; Li, S.; Li, Y.; Yu, V.; Alakhov, E. W. F.; Kabanov, A. V. "Distribution kinetics of a micelle-forming block copolymer Pluronic P85", J. Control. Release 2004, 100, 389-397.
26. Akash, M. S. H.; Rehman, K.; Sun, H.; Chen, S. "Sustained delivery of IL-1Ra from PF127 gel reduces hyperglycemia in diabetic GK rats", PLoS One 2013, 8, e55925.
27. Akash, M. S. H.; Rehman, K.; Chen, S. "Goto-kakizaki rats: Its suitability as non-obese diabetic animal model for spontaneous type 2 diabetes mellitus", Curr Diabetes Rev. 2013, 9, 387-396.
28. Mata, J. P.; Majhi, P. R.; Guo, C.; Liu, H. Z.; Bahadur, P. "Concentration, temperature, and salt-induced micellization of a triblock copolymer Pluronic L64 in aqueous media", J. Colloid Interf. Sci. 2005, 292, 548-556.
29. Kissel, T.; Li, Y.; Unger, F. "ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide)B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins", Adv. Drug Deliver. Rev. 2002, 54, 99-134.
30. Gariépy, E. R.; Leroux, J. C. "In situ-forming hydrogels: Review of temperature-sensitive systems", Eur. J. Pharm. Biopharm. 2004, 58, 409-426.
31. Fusco, S.; Borzacchiello, A.; Netti, P. "Perspectives on: PEO-PPO-PEO triblock copolymers and their biomedical applications", J. Bioact. Compat. Polym. 2006, 21, 149-164.
32. He, C.; Kim, S. W.; Lee, D. S. "In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery", J. Control. Release 2008, 127, 189-207.
33. ® -modified polycations in gene delivery", Curr. Opin. Colloid Interface Sci. 2006, 11, 217-223.
34. ®/chitosan) enhances the immune response to intranasally administered tetanus toxoid", Vaccine 2002, 20, 711-723.
35. Yoo, H. S. "Photo-cross-linkable and thermo-responsive hydrogels containing chitosan and Pluronic for sustained release of human growth hormone (hGH)", J. Biomater. Sci. Polymer. Ed. 2007, 18, 1429-1441.
36. Guo, D. D.; Xu, C. X.; Quan, J. S.; Song, C. K.; Jin, H.; Kim, D. D.; Choi, Y. J.; Cho, M. H.; Cho, C. S. "Synergistic anti-tumor activity of paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel in vitro and in vivo", Biomaterials 2009, 30, 4777-4785.
37. Hsu, S.; Leu, Y.; Hu, J.; Fang, J. "Physicochemical characterization and drug release of thermosensitive hydrogels composed of a hyaluronic acid/Pluronic F127 graft", Chem. Pharm. Bull. 2009, 57, 453-458.
38. Fang, J.; Hsu, S.; Leu, Y.; Hu, J. "Delivery of cisplatin from Pluronic co-polymer systems: liposome inclusion and alginate coupling", J. Biomat. Sci. Polym. E 2009, 20, 1031-1047.
39. Kwon, G. S. "Polymeric micelles for delivery of poorly water-soluble compounds", Crit. Rev. Ther. Drug Carr. Syst. 2003, 20, 357-403.
40. Torchilin, V. P.; Lukyanov, A. N.; Gao, Z.; Papahadjopoulos-Sternberg, B. "Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs", Proc. Natl. Acad. Sci. USA. 2003, 100, 6039-6044.
41. Akash, M. S. H.; Rehman, K.; Li, N.; Gao, J. Q.; Sun, H.; Chen, S. "Sustained delivery of IL-1Ra from Pluronic F127-based thermosensitive gel prolongs its therapeutic potentials", Pharm. Res. 2012, 29, 3475-3485.
42. Batrakova, E.; Han, H.; Alakhov, V.; Miller, D.; Kabanov, A. "Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers", Pharm. Res. 1998, 15, 850-855.
43. Kwon, S. H.; Kim, S. Y.; Ha, K. W.; Kang, M. J.; Huh, J. S.; Im, T. J.; Kim, Y. M.; Park, Y. M.; Kang, K. H.; Lee, S.; Chang, J. Y.; Lee, J.; Choi, Y. W. "Pharmaceutical evaluation of genistein-loaded pluronic micelles for oral delivery", Arch. Pharm. Res. 2007, 30, 1138-1143.
44. Kabanov, A. V.; Batrakova, E. V.; Miller, D. W. "Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier", Adv. Drug Deliv. Rev. 2003, 55, 151-164.
45. Spitzenberger, T. J.; Heilman, D.; Diekmann, C.; Batrakova, E. V.; Kabanov, A. V.; Gendelman, H. E.; Elmquist, W. F.; Persidsky, Y. "Novel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitis", J. Cereb. Blood Flow Metab. 2007, 27, 1033-1042.
46. Krupka, T.M.; Weinberg, B.D.; Wu, H.; Ziats, N. P.; Exner, A. A. "Effect of intratumoral injection of carboplatin combined with pluronic P85 or L61 on experimental colorectal carcinoma in rats", Exp. Biol. Med. 2007, 232, 950-957.
47. Croy, S. R.; Kwon, G. S. "The effects of Pluronic block copolymers on the aggregation state of nystatin", J. Control. Release 2004, 95, 161-171.
48. Croy, S. R.; Kwon, G. S. "Polysorbate 80 and Cremophor EL micelles deaggregate and solubilize nystatin at the core-corona interface", J. Pharm. Sci. 2005, 94, 2345-2354.
49. Johnston, T. P.; Punjabi, M. A.; Froelich, C. J. "Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice", Pharm. Res. 1992, 9, 425-434.
50. Wang, P. L.; Johnston, T. P. "Sustained-release interleukin-2 following intramuscular injection in rats", Int. J. Pharm. 1995, 113, 73-81.
51. Cen, X.; Ni, J.; Tan, T. "Investigation on recombinant hirudin via oral route", Peptides 2006, 27, 836-840.
52. ® F127 hydrogel for subcutaneous administration: In vitro and in vivo characterization", J Control Release 2007, 117, 387-395.
53. Akash, M. S. H.; Shen, Q.; Rehman, K.; Chen, S. "Interleukin-1 receptor antagonist: A new therapy for type 2 diabetes mellitus", J. Pharm. Sci. 2012, 101, 1647-1658.
54. Akash, M. S. H.; Rehman, K.; Chen, S. "Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus", J. Cell. Biochem. 2013, 114, 525-531.
55. Akash, M. S. H.; Rehman, K.; Chen, S. "An overview of valuable scientific models for diabetes mellitus", Curr. Diabetes Rev. 2013, 9(4), 286-293.
56. Akash, M. S. H.; Rehman, K.; Rasool, F.; Sethi, A.; Abrar, M. A.; Irshad, A.; Abid, A.; Murtaza, G. "Alternate therapy of type 2 diabetes mellitus (T2DM) with Nigella (Ranunculaceae)", J. Med. Plants Res. 2011, 5, 6885-6889.
57. Akash, M. S. H.; Rehman, K.; Chen, S. "Effects of coffee on type 2 diabetes mellitus", Nutrition 2014, 30, 755-763.
58. Akash, M. S. H.; Rehman, K.; Chen, S. "Spice plant Allium cepa: Dietary supplement for treatment of type 2 diabetes mellitus", Nutrition 2014, DOI: 10.1016/j.nut.2014.02.011.
59. Ehses, J. A.; Lacraz, G.; Giroix, M. H.; Schmidlin, F.; Coulaud, J.; Kassis, N.; Irminger, J. C.; Kergoat, M.; Portha, B.; Homo-Delarche, F.; Donath, M. Y. "IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat", Proc. Natl. Acad. Sci. USA. 2009, 106, 13998-14003.
60. Akash, M. S. H.; Rehman, K.; Chen, S. "Interleukin-1 receptor antagonist improves normoglycemia and insulin sensitivity in diabetic Goto-Kakizaki-rats", Eur. J. Pharmacol. 2013, 701, 87-95.
61. Akash, M. S. H.; Rehman, K.; Chen, S. "IL-1Ra and its delivery strategies: Inserting the association in perspective", Pharm Res. 2013, 30, 2951-2966.
62. Fonseca, V. "The role of basal insulin therapy in patients with type 2 diabetes mellitus", Insulin 2006, 1, 51-60.
63. Ghilzai, N. M. K. "New developments in insulin delivery", Drug Dev. Ind. Pharm. 2003, 29, 253-265.
64. Barichello, J. M.; Morishita, M.; Takayama, K.; Nagai, T. "Absorption of insulin from Pluronic F-127 gels following subcutaneous administration in rats", Int. J. Pharm. 1999, 184, 189-198.
65. Wang, Y.; Gao, J.; Li, F.; Ri, S.; Liang, W. "Triblock copolymer Pluronic F127 sustains insulin release and reduces initial burst of microspheres-in vitro and in vivo study", Colloid. Polym. Sci. 2006, 285, 233-238.
66. Nasir, F.; Iqbal, Z.; Khan, A.; Khan, J. A.; Khan, A.; Khuda, F.; Zakir, S.; Yousaf, N.; Khan, I.; Shah, Y.; Khan, M. I.; Shahbaz, N. "Development and evaluation of pluronic- and methylcellulose-based thermoreversible drug delivery system for insulin", Drug. Dev. Ind. Pharm. 2013, DOI: 10.3109/03639045.2013.831441.
67. Barichello, J. M.; Morishita, M.; Takayama, K.; Chiba, Y.; Tokiwa, S.; Nagai, T. "Enhanced rectal absorption of insulin-loaded Pluronic F-127gels containing unsaturated fatty acids", Int. J. Pharm. 1999, 183, 125-132.
68. Morishita, M.; Barichello, J.M.; Takayama, K.; Chiba, Y.; Tokiwa, S.; Nagai, T. "Pluronic F-127 gels incorporating highly purified unsaturated fatty acids for buccal delivery of insulin", Int. J. Pharm. 2001, 212, 289-293.
69. Das, N.; Madan, P.; Lin, S. "Development and in vitro evaluation of insulin-loaded buccal Pluronic F-127 gels", Pharm. Dev. Technol. 2010, 15, 192-208.
70. Das, N.; Madan, P.; Lin, S. "Statistical optimization of insulin-loaded Pluronic F-127 gels for buccal delivery of basal insulin", Pharm. Dev. Technol. 2012, 17, 363-374.
71. Pillai, O.; Panchagnula, R. "Transdermal delivery of insulin from poloxamer gel: Ex vivo and in vivo skin permeation studies in rat using iontophoresis and chemical enhancers", J. Control. Release 2003, 89, 127-140.
72. Garverick, H. A. "Ovarian follicular cysts in dairy cows", J. Dairy Sci. 1997, 80, 995-1004.
73. Meyers, P. J.; Bowman, T.; Blodgett, G.; Conboy, H. S.; Gimenez, T.; Reid, M. P.; Taylor, B. C.; Thayer, J.; Jöchle, W.; Trigg, T. E. "Use of the GnRH analogue, deslorelin acetate, in a slow release implant to accelerate ovulation in oestrous mares", Vet. Rec. 1997, 140, 249-252.
74. Wenzel, J. G.; Balaji, K. S.; Koushik, K.; Navarre, C.; Duran, S. H.; Rahe, C. H.; Kompella, U.B. "Pluronic F127 gel formulations of Deslorelin and GnRH reduce drug degradation and sustain drug release and effect in cattle", J. Control. Release 2002, 85, 51-59.
75. Na, D. H.; Youn, Y. S.; Lee, I. B.; Park, E. J.; Park, C. J.; Choon, K. L. "Effect of molecular size of PEGylated recombinant human epidermal growth factor on the biological activity and stability in rat wound tissue", Pharm. Dev. Technol. 2006, 11, 513-519.
76. Serno, T.; Geidobler, R.; Winter, G. "Protein stabilization by cyclodextrins in the liquid and dried state", Adv. Drug Deliv. Rev. 2011, 63, 1086-1106.
77. Prashar, D.; Cui, D.; Bandyopadhyay, D.; Luk, Y. Y. "Modification of proteins with cyclodextrins prevents aggregation and surface adsorption and increases thermal stability", Langmuir 2011, 27, 13091-13096.
78. Kim, E. Y.; Gao, Z. G.; Park, J. S.; Li, H.; Han, K. "rhEGF/HP- β-CD complex in poloxamer gel for ophthalmic delivery", Int. J. Pharm. 2002, 233, 159-167.
79. Choi, J. S.; Yoo, H. S. "Pluronic/chitosan hydrogels containing epidermal growth factor with wound-adhesive and photo-crosslinkable properties", J. Biomed. Mater. Res. A. 2010, 95, 564-573.
80. Katakam, M.; Ravis, W. R.; Banga, A. K. "Controlled release of human growth hormone in rats following parenteral administration of poloxamer gels", J. Control. Release 1997, 49, 21-26.
81. Katakam, M.; Ravis, W. R.; Golden, D. L.; Banga, A. K. "Controlled release of human growth hormone following subcutaneous administration in dogs", Int. J. Pharm. 1997, 152, 53-58.
82. Lee, J. B.; Chun, K. W.; Yoon, J. J.; Park, T. G. "Controlling degradation of acid-hydrolyzable Pluronic hydrogels by physical entrapment of poly(lactic acid-co-glycolic acid) microspheres", Macromol. Biosci. 2004, 4, 957-962.
83. Chun, K. W.; Lee, J. B.; Kim, S. H.; Park, T. G. "Controlled release of plasmid DNA from photo-cross-linked pluronic hydrogels", Biomaterials 2005, 26, 3319-3326.
84. Hennink, W. E.; van Nostrum, C. F. "Novel crosslinking methods to design hydrogels", Adv. Drug Deliv. Rev. 2002, 54, 13-36.
85. Slager, J.; Domb, A. J. "Biopolymer stereocomplexes", Adv. Drug Del. Rev. 2003, 55, 549-583.
86. de Jong, S. J.; De Smedt, S. C.; Wahls, M. W. C.; Demeester, J.; Kettenes-van den Bosch, J. J.; Hennink, W. E. "Novel self-assembled hydrogels by stereocomplex formation in aqueous solution of enantiomeric lactic acid oligomers grafted to dextran", Macromolecules 2000, 33, 3680-3686.
87. Lim, D. W.; Choi, S. H.; Park, T. G. "A new class of biodegradable hydrogels stereocomplexed between enantiomeric oligo-lactide side chains of poly (HEMA-g-OLA)s", Macromol. Rap. Comm. 2000, 21, 464-471.
88. Hennink, W. E.; de Jong, S. J.; Bos, G. W.; Veldhuis, T. F. J.; van Nostrum, C. F. "Biodegradable dextran hydrogels crosslinked by stereocomplex formation for the controlled release of pharmaceutical proteins", Int. J. Pharm. 2004, 277, 99-104.
89. Hiemstra, C.; Zhong, Z.; van Steenbergen, M. J.; Hennink, W. E.; Feijen, J. "Release of model proteins and basic fibroblast growth factor from in situ forming degradable dextran hydrogels", J. Control. Release 2007, 122, 71-78.
90. Chung, H. J.; Lee, Y.; Park, T. G. "Thermo-sensitive and biodegradable hydrogels based on stereocomplexed Pluronic multi-block copolymers for controlled protein delivery", J. Control. Release 2008, 127, 22-30.
91. Kim, M. R.; Park, T. G. "Temperature-responsive and degradable hyaluronic acid/Pluronic composite hydrogels for controlled release of human growth hormone", J. Control. Release 2002, 80, 69-77.
92. Duf̀es, C.; Muller, J. M.; Couet, W.; Olivier, J. C.; Uchegbu, I. F.; Schatzlein, A. G. "Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles", Pharm. Res. 2004, 21, 101-107.
93. Yoo, H. S.; Lee, J. E.; Chung, H.; Kwon, I. C.; Jeong, S. Y. "Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery", J. Control. Release 2005, 103, 235-243.
94. Bhattarai, N.; Ramay, H. R.; Gunn, J.; Matsen, F. A.; Zhang, M. "PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release", J. Control. Release 2005, 103, 609-624.
95. Merdan, T.; Kopecek, J.; Kissel, T. "Prospects for cationic polymers in gene and oligonucleotide therapy against cancer", Adv. Drug Deliv. Rev. 2002, 54, 715-758.
96. Azzam, T.; Domb, A. J. "Current developments in gene transfection agents", Curr. Drug Deliv. 2004, 1, 165-193.
97. Zaiss, A. K.; Muruve, D. A. "Immune responses to adeno-associated virus vectors", Curr. Gene. Ther. 2005, 5, 323-331.
98. Baum, C.; Kustikova, O.; Modlich, U.; Li, Z.; Fehse, B. "Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors", Hum. Gene. Ther. 2006, 17, 253-263.
99. Kabanov, A. V.; Zhu, J.; Alakhov, V. "Pluronic block copolymers for gene delivery", Adv. Genet. 2005, 53, 231-261.
100. Sung, S. J.; Min, S. H.; Cho, K. Y.; Lee, S.; Min, Y. J.; Yeom, Y. I.; Park, J. K. "Effect of polyethylene glycol on gene delivery of polyethylenimine", Biol. Pharm. Bull. 2003, 26, 492-500.
101. Mishra, S.; Webster, P.; Davis, M. E. "PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles", Eur. J. Cell Biol. 2004, 83, 97-111.
102. Cho, C. W.; Cho, Y. S.; Lee, H. K.; Yeom, Y. I.; Park, S. N.; Yoon, D. Y. "Improvement of receptor-mediated gene delivery to HepG2 cells using an amphiphilic gelling agent", Biotechnol. Appl. Biochem. 2000, 32, 21-26.
103. Kabanov, A. V.; Lemieux, P.; Vinogradov, S.; Alakhov, V. "Pluronic block copolymers: novel functional molecules for gene therapy", Adv. Drug Deliv. Rev. 2002, 54, 223-233.
104. Lemieux, P.; Guerin, N.; Paradis, G.; Proulx, R.; Chistyakova, L.; Kabanov, A.; Alakhov, V. "A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle", Gene Ther. 2000, 7, 986-991.
105. Gebhart, C. L.; Sriadibhatla, S.; Vinogradov, S.; Lemieux, P.; Alkahov, V.; Kabanov, V. A. "Design and formulation of polyplexes based on Pluronic-polyethyleneimine conjugates for gene transfer", Bioconjug. Chem. 2002, 13, 937-944.
106. March, K. L.; Madison, J.; Trapnell, B. C. "Pharmacokinetics of Adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapy", Hum. Gene Ther. 1995, 6, 45-53.
107. Feldman, L. J.; Pastore, C. J.; Aubailly, N.; Kearney, M.; Chen, D.; Perricaudet, M.; Steg, P. G.; Isner, J. M. "Improved efficiency of arterial gene transfer by use of poloxamer 407 as a vehicle for adenoviral vectors", Gene Ther. 1997, 4, 189-198.
108. Strappe, P. M.; Hampton, D. W.; Cachon-Gonzalez, B.; Fawcett, J. W.; Lever, A. "Delivery of a lentiviral vector in a Pluronic F127 gel to cells of the central nervous system", Eur. J. Pharm. Biopharm. 2005, 61, 126-133.
109. Mumper, J.; Rolland, A. P. "Plasmid delivery to muscle: recent advances in polymer delivery system", Adv. Drug Deliver. Rev. 1998, 30, 151-172.
110. Danko, I.; Fritz, J. D.; Jiao, S.; Hogan, K.; Latendresse, J. S. l.; Wolff, J. A. "Pharmacological enhancement of in vivo foreign gene expression in muscle", Gene Ther. 1994, 1, 114-121.
111. Griffith, L. G.; Naughton, G. "Tissue engineering-current challenges and expanding opportunities", Science 2002, 295, 1009-1014.
112. Park, J. S.; Oh, Y. K.; Yoon, H.; Kim, J. M.; Kim, C. K. "In situ gelling and mucoadhesive polymer vehicles for controlled intranasal delivery of plasmid DNA", J. Biomed. Mater. Res. 2003, 59, 144-151.
113. Meilander, N. J.; Parsumarthy, M. K.; Kowalczyk, T. H.; Cooper, M. J.; Bellamkonda, R. V. "Sustained release of plasmid DNA using lipid microtubules and agarose hydrogel", J. Control. Release 2003, 88, 321-331.
114. Walter, E.; Moelling, K.; Pavolvich, J.; Merkle, H. P. "Microencapsulation of DNA using poly(D, L-lactide-co-glycolide): stability issues and release characteristics", J. Control. Release 1999, 61, 361-374.
115. Luo, D.; Saltzman, W. M. "Synthetic DNA delivery system", Nat. Biotechnol. 2000, 18, 33-37.
116. Nof, M.; Shea, L. D. "Drug-releasing scaffolds fabricated from drug loaded microspheres", J. Biomed. Mater. Res. 2002, 59, 349-356.
117. Quick, D. J.; Anseth, K. S. "Gene delivery in tissue engineering: a photopolymer platform to coencapsulate cells and plasmid DNA", Pharm. Res. 2003, 20, 1730-1737.
118. Quick, D. J.; Anseth, K. S. "DNA delivery from photocrosslinked PEG hydrogels: encapsulation efficiency, release profiles, and DNA quality", J. Control. Release 2004, 96, 341-351.
119. Lu, D.; Hickey, A. J. "Pulmonary vaccine delivery", Expert Rev. Vaccines 2007, 6, 213-226.
120. Sullivan, V. J.; Mikszta, J.A.; Laurent, P.; Huang, J.; Ford, B. "Noninvasive delivery technologies: Respiratory delivery of vaccines", Expert Opin. Drug Deliv. 2006, 3, 87-95.
121. Todoroff, J.; Ucakar, B.; Inglese, M.; Vandermarliere, S.; Fillee, C.; Renauld, J. C.; Huygen, K.; Vanbever, R. "Targeting the deep lungs, Poloxamer 407 and a CpG oligonucleotide optimize immune responses to Mycobacterium tuberculosis antigen 85A following pulmonary delivery", Eur. J. Pharm. Biopharm. 2013, 84, 40-48.
122. Csaba, N.; Garcia-Fuentes, M.; Alonso, M. J. "Nanoparticles for nasal vaccination", Adv. Drug Deliv. Rev. 2009, 61, 140-157.
123. Clark, M. A.; Jepson, M. A.; Hirst, B. H. "Exploiting M cells for drug and vaccine delivery", Adv. Drug Del. Rev. 2001, 50, 81-106.
124. Perez, C.; Castellanos, I. J.; Costantino, H. R.; Al-Azzam, W.; Griebenow, K. "Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers", J. Pharm. Pharmacol. 2002, 54, 301-313.
125. Csaba, N.; Garcia-Fuentes, M.; Alonso, M. J. "The performance of nanocarriers for transmucosal drug delivery", Expert Opin. Drug Deliv. 2006, 3, 463-478.
126. Wang, X.; Liu, G.; Ma, J.; Guo, S.; Gao, L.; Jia, Y.; Li, X.; Zhang, Q. "In situ gel-forming system: an attractive alternative for nasal drug delivery", Crit. Rev. Ther. Drug. Carrier Syst. 2013, 30, 411-434.
127. Brockmeier, S. L.; Register, K. B.; Magyar, T.; Lax, A. J.; Pullinger, G. D.; Kunkle, R. A. "Role of the dermonecrotic toxin of Bordetella bronchiseptica in the pathogenesis of respiratory disease in swine", Infect. Immun. 2002, 70, 481-490.
128. Kang, M. L.; Jiang, H. L.; Kang, S. G.; Guo, D. D.; Lee, D. Y.; Cho, C. S.; Yoo, H. S. "Pluronic R® F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin", Vaccine 2007, 25, 4602-4610.
129. ® F127-based systemic vaccine delivery systems", Vaccine 2004, 22, 2396-2405.
130. Swanson-Biearman, B.; Krenzelok, E. P. "Delayed life-threatening reaction to anthrax vaccine", J. Toxicol. Clin. Toxicol. 2001, 39, 81-84.
131. Pisal, S. S.; Paradkar, A. R.; Mahadik, K. R.; Kadam, S. S. "Pluronic gels for nasal delivery of Vitamin B12. Part I: Preformulation study", Int. J. Pharm. 2004, 270, 37-45.
132. Lin, H. R.; Sung, K. C. "Carbopol/pluronic phase change solutions for ophthalmic drug delivery", J. Control. Release 2000, 69, 379-388.
133. Lee, S. Y.; Tae, G. "Formulation and in vitro characterization of an in situ gelable, photopolymerizable Pluronic hydrogel suitable for injection", J. Control. Release 2007, 119, 313-319.
134. Lee, S. Y.; Tae, G.; Kim, Y. H. "Thermal gellation and photo-polymerization of di-acrylated Pluronic F 127", J. Biomater. Sci. Polym. Ed. 2007, 18, 1335-1353.
135. Niu, G.; Du, F.; Song, L.; Zhang, H.; Yang, J.; Cao, H.; Zheng, Y.; Yang, Z.; Wang, Yang, G. H.; Zhu, S. "Synthesis and characterization of reactive poloxamer 407s for biomedical applications", J. Control. Release 2009, 138, 49-56.
136. Mayol, L.; Biondi, M.; Quaglia, F.; Fusco, S.; Borzacchiello, A.; Ambrosio, L.; La Rotonda, M. I. "Injectable thermally responsive mucoadhesive gel for sustained protein delivery", Biomacromolecules 2011, 12, 28-33.
137. Cohn, D.; Lando, G.; Sosnik, A.; Garty, S.; Levi, A. "PEO-PPO-PEO- based poly(ether ester urethane)s as degradable reverse thermo-responsive multiblock copolymers", Biomaterials 2006, 27, 1718-1727.
138. Liu, Y.; Zhu, Y. Y.; Wei, G.; Lu, W. Y. "Effect of carrageenan on poloxamer based in situ gel for vaginal use: Improved in vitro and in vivo sustained release properties", Eur. J. Pharm. Sci. 2009, 37, 306-312.